Therapeutics 3 Tutoring Exam 4 February 27 th, 2016 Lisa Hayes

Slides:



Advertisements
Similar presentations
TUBERCULOSIS This is the prompt slide for the TB Therapy section.
Advertisements

The TB Alliance-Bayer Moxifloxacin Deal
TUBERCULOSIS Pulmonary TB.
Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 9 Antifungal and Antiviral Agents.
ANTIFUNGAL DRUGS Fungal infections (mycoses) can be both superficial and systemic. Superficial infections (Oral and vulvovaginal candidiasis, Dermatophytosis,
7. Anti-TB regimen in special situations of liver disease, renal impairment, and pregnancy.
Ois generalPCPCryptococcus-Toxoplasma
Pulmonary TB. BY PROF. AZZA ELMedany Dr. Ishfaq Bukhari.
Module 3: Drug-Resistant TB. Learning Objectives Describe how drug resistance emerges Explain the difference between primary and secondary resistance.
Antimycobacterial drugs Tuberculosis Treatment of mycobacterial infections is complicated due: Limited information regarding antimycobacterial drug actions.
Initial Evaluation and Common Clinical Manifestations
Tuberculosis (TB) PHCL 442 Lab Discussion Jamilah Al-Saidan, M.Sc.
Chronic HIV Infection Clinical Manifestations Opportunistic Infections O.I. Prophylaxis.
Adult Immunization 2010 Herpes Zoster (Shingles) Segment This material is in the public domain This information is valid as of May 25, 2010.
Oropharyngeal Candidiasis in Patients with AIDS
Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology.
Unit 7 Treatment of TB: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers.
Social Pharmacy Lecture no. 8 Rational prescribing guidelines.
Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents Mucocutaneous Candidiasis Slide Set Prepared.
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. Chapter 89 Antimycobacterial Agents: Drugs for Tuberculosis, Leprosy,
Module 4 Basic Principles of Treatment. “ubo! ubo! ubo!” (cough for 2 weeks or more) Did not take medication medication In Loving Memory of In Loving.
1 Starting ART in the Context of Opportunistic Infections HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Anri Uys (MSc Pharmacology, BPharm NWU) Medicines Information Centre, Division of Clinical Pharmacology University of Cape Town.
TB 101 Part II Brenda Mayes, R. N. March TREATMENT TB DISEASE MDR XDR LATENT TB INFECTION.
Treatment Bed rest doesn’t affect outcome Hospitalisation: – Ill, smear positive, highly infectious patients – Esp in multi-drug resistant TB Continuous.
Copyright (c) 2004 Elsevier Inc. All rights reserved. Antimycobacterial Agents: Drugs for Tuberculosis, Leprosy, and Mycobacterium avium Complex Infections.
Chemotherapy of Tuberculosis By Prof. Azza El-Medany.
Anti-viral Drugs.. Introduction The viral agents kill viruses by inhibiting their ability to replicate, but there are currently only about a dozen such.
Prophylaxis of Opportunistic Infections
Phase I Issues for Novel TB Drugs Dakshina M. Chilukuri, Ph.D. Office of Clinical Pharmacology and Biopharmaceutics, FDA OPEN FORUM ON KEY ISSUES IN TB.
Pulmonary TB. BY PROF.  AZZA ELMedany OBJECTIVES  At the end of lecture, the students should:  Discuss the etiology of tuberculosis  Discuss the.
Antitubercular Agents. Tuberculosis, “TB”Tuberculosis, “TB” Caused by Mycobacterium tuberculosisCaused by Mycobacterium tuberculosis Antitubercular agents.
Mycobacterial, Fungal, & Parasitic Infections Medications for Infection ADN 110/cohort 131.
Raniah Al-Jaizani M.Sc Lecturer, Clinical Pharmacy Dept.
Chemotherapy Of Mycobacterial Infections Dr.Mohamed daood PhD student in Pharmacology.
ANTIFUNGAL DRUGS PHARM 514 Douglas Black, Pharm.D. Associate Professor School of Pharmacy University of Washington
Pharmacokinetics: Digoxin Allie Punke
TUBERCULOSIS. Tuberculosis is a chronic granulomatous disease and is one of the world’s most widespread and deadly illness. It is commonly called as Consumption.
Therapeutics IV Tutoring Lisa Hayes March 17, 2016.
ALLIE PUNKE PHARMACOKINETICS: ANTIEPILEPTIC DRUGS.
Treatment Regimens for Pulmonary Tuberculosis Caused by Drug- Susceptible Organisms Initial PhaseContinuation Phase RegimenDrugs Interval and Doses (Minimal.
Depart. of Pulmonology R4 백승숙. 1. INTRODUCTION 2. BACKGROUND 3. DIAGNOSIS OF LATENT TB INFECTION 4. CHEMOPROPHYLAXIS 5. RISKS OF TUBERCULOSIS AND OF DRUG-INDUCED.
Pharmacokinetics: Warfarin
Communicating with Patients and Providers HIV Care and ART: A Course for Pharmacists.
Prepared by the AETC National Coordinating Resource Center based on recommendations from the CDC, National Institutes of Health, and HIV Medicine Association/Infectious.
TREATMENT OF TUBERCULOSIS: Prevention: BCG vaccination: It does not prevent infection but limits multiplication and spread of following infection so prevents.
Antimycobacterial Drugs September Mycobacteria Mycobacteria are intrinsically resistant to most antibiotics. Because they grow slowly compared with.
Antifungal drugs Lec Dr. Naza M. Ali
Tuberculosis (TB) PHCL 442 Lab Discussion 4 Raniah Al-Jaizani M.Sc.
More Antibiotics Tutoring for Pharmacology
Therapeutics 3: Antibiotics Tutoring
Drugs used in tuberculosis
Treatment of TB Disease
. Antitubercular Drugs.
Treatment of Latent TB Infection (LTBI)
Pharmacokinetics: Warfarin
Time to update guidelines on screening for latent tuberculosis infection in dermatologic patients being treated with tumor necrosis factor-alfa inhibitors 
Anti-fungal agents Problem: Fungi are eukaryotes
Use of NOACs is contraindicated for AF patients with mechanical prosthetic valves or moderate- severe mitral stenosis (usually of rheumatic origin). Although.
Pharmacokinetics: immunosuppressive drugs
Antiviral Agents.
Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs
Time to update guidelines on screening for latent tuberculosis infection in dermatologic patients being treated with tumor necrosis factor-alfa inhibitors 
Battling the Flu: Latest Advances in the Influenza Treatment Arsenal
Pharmacology 3 Antimycobacterial drugs Lecture 12 By Prof. Dr
TUBERCULOSIS Pulmonary TB Drug therapy Dr. Ishfaq Dr. Aliah.
Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs
Lecture 5 By Prof. dr. Mohammed Fahmy
Presentation transcript:

Therapeutics 3 Tutoring Exam 4 February 27 th, 2016 Lisa Hayes

Outline Antivirals Tuberculosis Fungal Infections

Things to Remember Drug interactions Mechanism of action Any indications listed that are focused on Side Effects Resistance Patterns

An immunosuppressed patient has presented to your hospital with a systemic fungal infection. It has been decided that AmpB is the most appropriate agent to treat her infection. Which of the most appropriate actions is necessary as you administer her therapy? A – Monitor potassium and sodium. Regular checking of SCR. B – Monitor potassium and magnesium. C – Monitor potassium and sodium. Provide lipid formulation. Provide hydration after administration. D – Monitor potassium and magnesium. Provide lipid formulation. Provide hydration before administration.

Which two interactions are affected by Fluconazole most? A – CYP2C19, CYP3A4 B – CYP2C9, CYP2C19 C – CYP3A4, CYP1A2 D – CYP3A4, CYP2C9

Which of the following drugs needs an acidic environment for the oral form to provide proper absorption? A – Mycamine B – Itraconazole C – Fluconazole D – Voriconazole

Itraconazole + which of the following drugs can increase the risk of prolonged QT? A – methadone B – lovastatin C – felodipine D - lurasidone

Voriconazole is the DOC for which of the following because it provide fungicidal activity? A – Blastomyces B – Aspergillosus C – Cryptococcus D- Candida

The IV formulation of Voriconazole is not reccomended beyond what CRCL? A – 25 B – 30 C – 45 D – 50

Which drug must be dose reduced for hepatic disease? A – Mycamine B – Caspofungin C – Fluconazole D - Itraconazole

Which two forms of Candida have intrinsic resistance to azoles? A – albicans, galbrata B – krusei, albicans C – krusei, galbrata D – lusitaniae, albicans

Antiviral Infections

Things to Remember Know which type of virus (DNA v RNA) Side effects of medications Dosing for Zoster, HSV Neuraminidase inhibitors – Drugs, contraindications, dosages

What age is the Zoster vaccine recommended for? A – over 70 B – over 60 C – over 55 D – over 50

Acyclovir can cause which of the following side effects? A – diarrhea B – crystalline nephropathy C – peripheral neuropathy D – optic neuritis

Which of the following is the appropriate treatment for HSV for an initial episode? A – Acyclovir 500mg TID x 3-5 days B – Valtrex 1gm BID x 3-5days C – Valtrex 1gm BID x 7-10days D – Famvir 500mg BID x 5-10day

Which drug is preferred for treatment of Zoster? A – Valtrex B – Acyclovir C – Ganciclovir D - Famvir

What drug is used for treatment of CMV retinitis? A – Ganciclovir (5mg/kg IV q12hours) B – Acyclovir (7mg/kg IBW IV q12 hours) C – Famvir (10mg/kg IV q12 hours)

Which drug should be avoided in a patient with a history of COPD? A – Tamiflu B – Zanamivir C – Peramivir

Tuberculosis

Things to Remember Drug therapy – RIPE Treatment for latent TB Drug side effects – Any treatment available Acid fast bacilli DOT Hepatitis Failing Regimens

Which of the following RIPE drugs is the strongest inducer? A – Rifampin B – Isonizaid C – Pyrazanimide D – Ethambutol

A repeat culture at 2mo is indicated when treating a patient for TB. For patient BB, her repeat culture is positive. What should you recommend for therapy at this time ? A – Continue therapy for additional 7 months with all RIPE drugs. B – Continue therapy for additional 4 months with all RIPE drugs. C – Continue therapy for additional 7 months with R and I drugs. D – Continue therapy for additional 4 months with R and I drugs.

A 65 year old patient on RIPE therapy presents with elevated LFTS. His LFTs are 3x the upper limit of normal. He is experiencing no side effects or adverse effects at this time. What should you recommend? A – Discontinue all drugs. B – Discontinue isoniazid. C – Recheck LFTs. D – LFTs – what?

A patient is on Rifampin for treatment of latent TB. She is also on warfarin for treatment of her DVT. She is also using hormonal birth control against the advice of her pharmacist. What would you need to counsel her on? A – Increased efficacy of warfarin B – Decreased efficacy of warfarin C – Increased efficacy of OCP D – decreased efficacy of OCP

When starting a patient on Isoniazid, what other agent is recommended to reduce the risk of peripheral neurotoxicity? A – Vit B12 B – Vit B1 C – Vit B6 D – Vit C

A patient is started on Rifampin for treatment of his latent TB. He uses Verapamil for treatment of his high BP. Should you recommend any changes? A – Increase dose of Verapamil B – Decrease dose of Verapamil C – Change Verapamil to another agent D – No change necessary

Which agent is preferred in AIDS patient due to the interaction profile? A – Rifabutin B – Rifampin

Which drug in the RIPE regimen is often neglected if sensitivity to the other agents is known? A – Rifampin B – Isoniazid C – Pyrazinamide D - Ethambutol